Clinical Trials Related to Pancreatic Ductal Adenocarcinoma

Related studies linked through entity extraction aliases.

A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

Status: RECRUITING
Phase: PHASE2/PHASE3

A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

Status: RECRUITING
Phase: PHASE1

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Status: RECRUITING
Phase: PHASE1/PHASE2

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Status: RECRUITING
Phase: PHASE1

Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers

Status: NOT_YET_RECRUITING
Phase: NA

Study for AZD4360 in Participants With Advanced Solid Tumours

Status: RECRUITING
Phase: PHASE1/PHASE2

A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas

Status: RECRUITING
Phase: PHASE1

Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma

Status: RECRUITING
Phase: PHASE2

Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types

Status: RECRUITING
Phase: PHASE2/PHASE3

Reinforced Pancreaticojejunostomy With or Without glubran2

Status: RECRUITING
Phase: PHASE2

Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center

Status: ACTIVE_NOT_RECRUITING
Phase: NA

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Status: RECRUITING
Phase: PHASE1/PHASE2

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

Status: RECRUITING
Phase: PHASE1

AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort

Status: RECRUITING
Phase: N/A

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer

Status: RECRUITING
Phase: N/A

A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors

Status: RECRUITING
Phase: PHASE1/PHASE2

Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC

Status: WITHDRAWN
Phase: PHASE1/PHASE2

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

Status: RECRUITING
Phase: PHASE1

Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment

Status: RECRUITING
Phase: NA